Angiotech Sells Interventional Business To Argon Medical Devices
This article was originally published in The Pink Sheet Daily
The deal will allow Angiotech to pay off all of its debt obligations and will bring the interventional products business, which includes biopsy devices and drainage catheters, back to its former owners.
You may also be interested in...
Recent 510(k) clearances include Andrew Technologies’ HydraSolve lipoplasty system for fat reduction; Insulet’s next-generation, tubeless OmniPod insulin pump; and PhysioSonics’ Presto 1000 cerebral blood flow monitor.
Former CMS coverage director Louis Jacques talks about the strong future ahead he envisions for the Medicare coverage-with-evidence-development program and new coverage policies that will be implemented for investigational device exemption trials.
Reimbursement Briefs: Pfizer Joins Big Data Group; Part D Protected Classes; Wikipedia Partners With Cochrane Collaboration
Pfizer is among seven organizations joining the Optum Labs research collaborative; CMS Coverage and Analysis Group Director Louis Jacques moving to private sector, more news in brief.